Versant Venture Management as of Dec. 31, 2025
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics Common Stock (GLUE) | 45.5 | $69M | 4.4M | 15.68 | |
| Lenz Therapeutics Common Stock (LENZ) | 28.1 | $43M | 2.7M | 16.00 | |
| Jade Biosciences Common Stock (JBIO) | 15.6 | $24M | 1.5M | 15.43 | |
| CRISPR Therapeutics Common Shares (CRSP) | 5.2 | $7.8M | 149k | 52.44 | |
| Contineum Therapeutics Common Stock (CTNM) | 4.1 | $6.2M | 543k | 11.43 | |
| Skye Bioscience Common Stock (SKYE) | 1.0 | $1.5M | 2.0M | 0.75 | |
| Tempest Therapeutics Common Stock | 0.5 | $774k | 270k | 2.87 |
